Natural-looking results begin with an individualized plan
Your anatomy, expression and goals guide every recommendation—so the result still feels unmistakably like you.
The short answer
What is Jeuveau®?
Jeuveau® is prabotulinumtoxinA-xvfs, and it is the only one of the four that exists purely for aesthetics. Its FDA indication is the temporary improvement in the appearance of moderate-to-severe glabellar lines associated with corrugator and/or procerus muscle activity in adults — and its boxed warning states plainly that it is not approved for spasticity or any condition other than glabellar lines. Where the other three carry long lists of medical indications, Jeuveau® was developed and approved for this one cosmetic use.
Concerns it may address
Frown lines between the brows — the single labeled use
Adults seeking treatment of the glabellar complex specifically
Patients comparing toxin options for the frown-line area
Anyone who wants the product choice kept narrow and on label
Choosing between toxins
How Jeuveau® differs from Botox®, Dysport and Xeomin
Jeuveau® is the narrowest product of the four, and that narrowness is the point rather than a limitation.
It is cosmetic-only by design
Botox® Cosmetic, Dysport® and Xeomin® all share a molecule with therapeutic products carrying indications for conditions like spasticity, cervical dystonia and chronic sialorrhea. Jeuveau® does not. Its label is one cosmetic indication, and its boxed warning says so explicitly.
Its label covers the glabella alone
The indication names the corrugator and procerus muscles — the frown-line complex between the brows. Xeomin® and Botox® Cosmetic carry broader cosmetic labeling across the upper face.
Its units are its own, like every other toxin
A Jeuveau® unit is not a Botox®, Dysport® or Xeomin® unit. If you are moving to Jeuveau® from another product, the provider builds a new dose from your anatomy and prior response rather than converting a number.
Product selection is a clinical decision made with you at consultation. Nothing here is a recommendation for a specific product, and no toxin can be dosed from a web page.
Candidacy
Who may—or may not—be a candidate
Who may be considered
Adults who want the frown lines between their brows treated, and nothing else on this visit. Jeuveau®’s indication is the glabellar complex — the corrugator and procerus muscles — and its boxed warning states plainly that it is not approved for spasticity or any condition other than glabellar lines. A good candidate understands the result is temporary, that asymmetry is possible, and that a narrow label is a reason for confidence in that area rather than a limitation.
When treatment may not be appropriate
Treatment may be deferred for pregnancy or breastfeeding, active infection at an injection site, known allergy to an ingredient, certain neuromuscular disorders, or symptoms that require medical evaluation. Tell the provider about all medications, supplements, prior toxin products and any swallowing or breathing problems. If your goal is the forehead, the outer eye or the neck, Jeuveau® is not the product for it and your provider will say so.
At a glance
Treatment facts
These are practical planning ranges, not promises. Your consultation determines the exact plan.
Treatment time
About 15–30 minutes
Comfort / anesthesia
Brief pinches; topical numbing is usually optional
Typical downtime
Usually minimal; small bumps or bruising may occur
When changes may appear
Often begins within several days; allow up to 2 weeks to assess
How long results may last
Commonly about 3–4 months
Treatments commonly considered
One visit, then reassessment or maintenance as appropriate
Your visit
What happens during treatment
Assess the glabella
Your provider reviews health history, prior toxin use and how the corrugator and procerus muscles pull when you frown. This is the area Jeuveau® is approved for.
Treat the area
Expression patterns are mapped and the skin is cleansed. Small measured injections are placed with a fine needle, dosed from your own muscle strength rather than converted from another product.
Review and follow up
You receive aftercare and a follow-up window. Do not judge symmetry before the product has had time to settle, which can take up to two weeks.
Informed choice
Important risks, limitations and alternatives
Risks & limitations
Expected effects can include temporary redness, tenderness, bruising, swelling or asymmetry. Every botulinum toxin product carries a boxed warning about distant spread of toxin effect: rare but serious risks include swallowing, speaking or breathing difficulty. Units of one product cannot be compared to or converted into units of another. Treatment cannot be guaranteed and must follow an individualized examination.
Alternatives to discuss
No treatment or skincare for surface-quality goals
Another FDA-approved botulinum toxin, recognizing units cannot be converted directly
Dermal filler or biostimulator when volume—not muscle movement—is the primary concern
Laser or resurfacing treatments for pigment, texture and fine etched lines
Clinical judgment
Why provider experience matters
Small differences in depth, angle, dose and muscle selection change the outcome. An experienced medical injector can distinguish dynamic lines from volume loss, protect brow and eyelid function, plan around asymmetry and recognize complications early.
Identity Aesthetics approach
Diagnosis and anatomy before a product or device
Conservative planning with candid limitations
Licensed-provider supervision and complication readiness
In-office and telehealth boundaries stated clearly
Access & cost
In-office versus telehealth
Treatment is in-office only. Telehealth can answer general questions, but facial examination, consent and injections occur at an Identity Aesthetics location.
Pricing: From $14 per unit. Final cost depends on the number of units selected after assessment. Always ask about current promotions and volume savings.
The goal can be subtle softening with natural movement. Your desired finish, anatomy and dose are discussed before treatment; no injector can promise an exact appearance.
Can I switch toxin brands?
Sometimes, but each product has its own formulation and labeled dosing. Units are not interchangeable, so the provider plans a new dose rather than using a simple conversion.
When should I call the office?
Contact the practice promptly for concerning weakness, eyelid or brow changes, severe headache, vision changes or any unexpected symptom. Seek emergency care for trouble breathing, swallowing or speaking.
Medical-content evidence review: July 30, 2026. Content is written for patient education and structured from current primary regulatory, labeling and professional sources. It has not been individualized to your medical history. Product labeling and guidance can change; a licensed Identity Aesthetics provider confirms current suitability, informed consent and treatment details before care.
Your next step
Make an informed plan
Bring your goals, questions, medication list and prior treatment history. We will help you decide whether Jeuveau®—or an alternative—makes sense.